Monitoring the effect of chemotherapy in a mixed glioma by C-11-methionine PET

被引:44
作者
Herholz, K
Kracht, LW
Heiss, WD
机构
[1] Univ Cologne, Neurol Klin, Max Planck Inst Neurol Forsch, D-50931 Cologne, Germany
[2] Univ Cologne, Dept Neurol, Cologne, Germany
关键词
glioma; chemotherapy; positron emission tomography; C-11-methionine; oligodendroglioma; procarbazine; treatment monitoring;
D O I
10.1177/1051228403013003012
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The effect of chemotherapy with procarbazine, CCNU, and vincristine in an anaplastic oligoastrocytoma was monitored by repeated positron emission tomography (PET) with C-11-methionine (C-11-MET). Chemotherapy caused a continuous decline of active tumor volume at a rate of approximately 2.4% per day, resulting in complete remission that persisted until the end of follow-up at 3 years. Thus, the authors conclude that C-11 -MET PET may be useful for monitoring chemotherapy in gliomas and deserves further study.
引用
收藏
页码:269 / 271
页数:3
相关论文
共 23 条
[1]  
Brock CS, 2000, BRIT J CANCER, V82, P608
[2]   Malignant gliomas. [J].
Burton E.C. ;
Prados M.D. .
Current Treatment Options in Oncology, 2000, 1 (5) :459-468
[3]   BRAIN-TUMOR PROTEIN-SYNTHESIS AND HISTOLOGICAL GRADES - A STUDY BY POSITRON EMISSION TOMOGRAPHY (PET) WITH C-11-L-METHIONINE [J].
BUSTANY, P ;
CHATEL, M ;
DERLON, JM ;
DARCEL, F ;
SGOUROPOULOS, P ;
SOUSSALINE, F ;
SYROTA, A .
JOURNAL OF NEURO-ONCOLOGY, 1986, 3 (04) :397-404
[4]   STEROID-INDUCED CT CHANGES IN PATIENTS WITH RECURRENT MALIGNANT GLIOMA [J].
CAIRNCROSS, JG ;
MACDONALD, DR ;
PEXMAN, JHW ;
IVES, FJ .
NEUROLOGY, 1988, 38 (05) :724-726
[5]  
Goldman S, 1997, J NUCL MED, V38, P1459
[6]   Chemotherapy response criteria in malignant glioma [J].
Grant, R ;
Liang, BC ;
Slattery, J ;
Greenberg, HS ;
Junck, L .
NEUROLOGY, 1997, 48 (05) :1336-1340
[7]   11C-methionine PET for differential diagnosis of low-grade gliomas [J].
Herholz, K ;
Hölzer, T ;
Bauer, B ;
Schröder, R ;
Voges, J ;
Ernestus, RI ;
Mendoza, G ;
Weber-Luxenburger, G ;
Löttgen, J ;
Thiel, A ;
Wienhard, K ;
Heiss, WD .
NEUROLOGY, 1998, 50 (05) :1316-1322
[8]  
Kaschten B, 1998, J NUCL MED, V39, P778
[9]  
Langen KJ, 1997, J NUCL MED, V38, P517
[10]  
Levivier M, 1996, J NEUROSURG, V84, P148